{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "DJ-1",
        "Protein_Change": {
          "ref": "E",
          "alt": "K",
          "position": "163"
        },
        "variant_string_id": "DJ-1 E163K"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The E163K mutant does not show altered subcellular localization. Characteristics include weakness and muscle atrophy in the upper and lower extremities, speech deficits, cognitive impairment, and parkinsonism. Because of the early onset and more extensive phenotype associated with this mutation, its analysis and an understanding of how it can lead to disease may provide new insights into the molecular basis of the disease.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay, which is mitochondrial dysfunction related to early-onset Parkinson's disease."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The assay used is a subcellular localization study using Western blot with various antibodies (DJ5, 691, Tim23, ERK1/2) and experiments were shown in duplicates.",
          "judgment": "Yes",
          "reasoning": "The general class of assay (subcellular localization) effectively models the disease mechanism (mitochondrial dysfunction) as protein localization is critical for proper function.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Experiments are shown in duplicates. The paper mentions the use of WT as a control but does not specify the use of known pathogenic or benign variant controls.",
          "judgment": "No",
          "reasoning": "While basic controls (WT) are mentioned, there is no explicit mention of positive or negative controls (known pathogenic or benign variants).",
          "next_step_or_outcome": "Proceed to Sub-step 3b"
        },
        {
          "step_name": "Step 3b: Accepted/Validated Assay",
          "extracted_paper_info": "The assay is a standard technique in the field (Western blot and subcellular localization).",
          "judgment": "Yes",
          "reasoning": "The assay is a broadly accepted and validated method in the field, though specific controls beyond WT are lacking.",
          "next_step_or_outcome": "Functional evidence strength is Max PS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The E163K variant shows altered subcellular localization, suggesting potential pathogenicity. However, the evidence is supporting due to the lack of comprehensive controls and statistical analysis."
    }
  ]
}